These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3471272)

  • 1. The value of CA 125 serum assay in the management of ovarian cancer.
    Lambert J
    Br J Obstet Gynaecol; 1987 Mar; 94(3):193-5. PubMed ID: 3471272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
    Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
    Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    Patsner B; Mann WJ; Chalas E
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G; Zippel HH; Würz H
    Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 6. CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer.
    Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1990 Sep; 36(3):221-8. PubMed ID: 2199246
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical relevance of the CA-125 assay for the management of patients with ovarian carcinoma.
    Raju RN; Dalbow MH; Pugh RP; Concannon JP; Zidar BL; Zamerilla CF; Schenken LL
    Prog Clin Biol Res; 1987; 248():289-97. PubMed ID: 3478733
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
    Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
    Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
    [No Abstract]   [Full Text] [Related]  

  • 10. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
    Canney PA; Wilkinson PM; James RD; Moore M
    Br J Cancer; 1985 Jul; 52(1):131-3. PubMed ID: 2410004
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of serum CA 125 in ovarian cancers.
    Yuan CC; Ng HT; Yeh SH; Jeng FS; Chen SL; Tsai LC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):153-60. PubMed ID: 3484240
    [No Abstract]   [Full Text] [Related]  

  • 12. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
    Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
    Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for ovarian cancer by CA-125 measurement.
    Cruickshank DJ
    Lancet; 1988 Mar; 1(8584):540-1. PubMed ID: 2893964
    [No Abstract]   [Full Text] [Related]  

  • 16. CA 15-3 serum levels in ovarian cancer.
    Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
    Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
    Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
    Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of CA-125 levels in advanced ovarian cancer.
    Patsner B; Day TG
    Am J Obstet Gynecol; 1987 Feb; 156(2):440-1. PubMed ID: 3469916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
    Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
    Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour-associated antigen CA 125 in patients with ovarian cancer.
    Heinonen PK; Tontti K; Koivula T; Pystynen P
    Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.